IPI-493 Terminated Phase 1 Trials for Advanced Malignant Neoplasm Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00724425
A Phase 1 Dose Escalation Study of IPI-493